US Stock MarketDetailed Quotes

VANI Vivani Medical

Watchlist
  • 1.440
  • -0.010-0.69%
Close Nov 29 13:00 ET
  • 1.450
  • +0.010+0.69%
Post 16:40 ET
85.30MMarket Cap-3348P/E (TTM)

Vivani Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-11.69%6.31M
-18.88%5.68M
-5.67%6.23M
26.95%26.97M
-20.19%6.22M
31.23%7.14M
71.35%7M
68.95%6.6M
59.43%21.24M
119.56%7.79M
Selling and administrative expenses
-22.09%2.11M
-30.93%2.17M
-5.48%2.5M
41.36%10M
-55.13%1.51M
70.54%2.7M
255.09%3.14M
115.47%2.65M
204.70%7.07M
486.91%3.36M
-General and administrative expense
-22.09%2.11M
-30.93%2.17M
-5.48%2.5M
41.36%10M
-55.13%1.51M
70.54%2.7M
255.09%3.14M
115.47%2.65M
204.70%7.07M
486.91%3.36M
Research and development costs
-5.36%4.2M
-9.08%3.51M
-5.79%3.73M
19.75%16.97M
6.35%4.71M
15.08%4.44M
20.64%3.86M
47.63%3.96M
28.79%14.17M
48.81%4.43M
Operating profit
11.69%-6.31M
18.88%-5.68M
5.67%-6.23M
-26.95%-26.97M
20.19%-6.22M
-31.23%-7.14M
-71.35%-7M
-68.95%-6.6M
-59.43%-21.24M
-119.56%-7.79M
Net non-operating interest income expense
Other net income (expense)
-25.97%268K
-31.87%325K
-33.57%188K
-82.14%1.31M
-62.25%191K
-94.73%362K
3,081.25%477K
1,764.71%283K
1,236.73%7.35M
802.78%506K
Other non- operating income (expenses)
-25.97%268K
-31.87%325K
-33.57%188K
-82.14%1.31M
-62.25%191K
-94.73%362K
3,081.25%477K
1,764.71%283K
1,236.73%7.35M
802.78%506K
Income before tax
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
Income tax
Net income
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
Net income continuous Operations
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
Minority interest income
Net income attributable to the parent company
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.93%-6.04M
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
Basic earnings per share
15.38%-0.11
23.08%-0.1
0.00%-0.12
-38.89%-0.5
38.89%-0.11
-425.00%-0.13
-60.72%-0.13
-1.20%-0.12
7.69%-0.36
-64.55%-0.18
Diluted earnings per share
15.38%-0.11
23.08%-0.1
0.00%-0.12
-38.89%-0.5
38.89%-0.11
-425.00%-0.13
-60.72%-0.13
-1.20%-0.12
7.69%-0.36
-64.55%-0.18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -11.69%6.31M-18.88%5.68M-5.67%6.23M26.95%26.97M-20.19%6.22M31.23%7.14M71.35%7M68.95%6.6M59.43%21.24M119.56%7.79M
Selling and administrative expenses -22.09%2.11M-30.93%2.17M-5.48%2.5M41.36%10M-55.13%1.51M70.54%2.7M255.09%3.14M115.47%2.65M204.70%7.07M486.91%3.36M
-General and administrative expense -22.09%2.11M-30.93%2.17M-5.48%2.5M41.36%10M-55.13%1.51M70.54%2.7M255.09%3.14M115.47%2.65M204.70%7.07M486.91%3.36M
Research and development costs -5.36%4.2M-9.08%3.51M-5.79%3.73M19.75%16.97M6.35%4.71M15.08%4.44M20.64%3.86M47.63%3.96M28.79%14.17M48.81%4.43M
Operating profit 11.69%-6.31M18.88%-5.68M5.67%-6.23M-26.95%-26.97M20.19%-6.22M-31.23%-7.14M-71.35%-7M-68.95%-6.6M-59.43%-21.24M-119.56%-7.79M
Net non-operating interest income expense
Other net income (expense) -25.97%268K-31.87%325K-33.57%188K-82.14%1.31M-62.25%191K-94.73%362K3,081.25%477K1,764.71%283K1,236.73%7.35M802.78%506K
Other non- operating income (expenses) -25.97%268K-31.87%325K-33.57%188K-82.14%1.31M-62.25%191K-94.73%362K3,081.25%477K1,764.71%283K1,236.73%7.35M802.78%506K
Income before tax 10.93%-6.04M17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M
Income tax
Net income 10.93%-6.04M17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M
Net income continuous Operations 10.93%-6.04M17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M
Minority interest income
Net income attributable to the parent company 10.93%-6.04M17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.93%-6.04M17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M
Basic earnings per share 15.38%-0.1123.08%-0.10.00%-0.12-38.89%-0.538.89%-0.11-425.00%-0.13-60.72%-0.13-1.20%-0.127.69%-0.36-64.55%-0.18
Diluted earnings per share 15.38%-0.1123.08%-0.10.00%-0.12-38.89%-0.538.89%-0.11-425.00%-0.13-60.72%-0.13-1.20%-0.127.69%-0.36-64.55%-0.18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data